Lipocalin-2/NGAL ELISA DY1757-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemLipocalin-2/NGAL ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY1757-05
Quantity1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
ApplicationsELISA
Detection Range78.10 - 5000 pg/mL
ReactivityHuman
Detection TargetLipocalin-2/NGAL
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Namelipocalin 2
NCBI Gene Aliases24p3, MSFI, NGAL, p25

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?Diagnostics (Basel)August 5, 2025Noemí Del Toro-Cisneros, José C. Páez-Franco, Miguel A. Martínez-Rojas, Isaac González-Soria, Juan Antonio Ortega-Trejo, Hilda Sánchez-Vidal, Norma A. Bobadilla, Alfredo Ulloa-Aguirre, Olynka Vega-Vegazero. Urinary concentrations of NGAL and KIM-1 were analyzed with commercially available ELISA kits (DY1757-05 for NGAL, and DY1750B for KIM-1; R&D Systems, Minneapolis, MN, USA), following the manufacturer’s instructions

(2) Inhibition and evasion of neutrophil microbicidal responses by Legionella longbeachaemBioFebruary 5, 2025Hanford HE, Price CTD, Uriarte S, Abu Kwaik Y.

(3) SARS-CoV-2 Spike Protein Amplifies the Immunogenicity of Healthy Renal Epithelium in the Presence of Renal Cell CarcinomaCellsDecember 10, 2024Somova M, Simm S, Ehrhardt J, Schoon J, Burchardt M, Pinto PC.DuoSet,DY8139-05 R&D Systems,HUman IL-8/CXCL8 DuoSet,DY208 R&D Systems,Human Lipocalin-2/NGAL DuoSet,DY1757-05 R&D Systems,HumanTNF-alpha DuoDet,DY210 ELISA kits used for the detection of immune secretions.

(4) GDF15 and LCN2 for early detection and prognosis of pancreatic cancerTranslational OncologyDecember 1, 2024Xinxia Zhu, Brennan Olson, Dove Keith, Mason A Norgard, Peter R Levasseur, Parham Diba, Sara Protzek, Ju Li, Xiaolin Li, Tetiana Korzun, et al.enzyme-linked immunosorbent assay (ELISA) kits following the manufacturers’ instructions (R&D Systems, catalog # DY957, DY1757-05, DY206-05, DY6385-05, DY1857-05, DY406-05). Human CA19-9 in patient serum was also measured using ELISA

(5) The association between HIV-1 Tat and Vif amino acid sequence variation, inflammation and Trp-Kyn metabolism: an exploratory investigationBMC infectious diseasesSeptember 9, 2024Williams ME, Asia LK, Lindeque Z, Jansen van Vuren E.

(6) Effects of fructan and gluten on gut microbiota in individuals with self-reported non-celiac gluten/wheat sensitivity-a randomised controlled crossover trialBMC medicineSeptember 4, 2024Herfindal AM, Nilsen M, Aspholm TE, Schultz GIG, Valeur J, Rudi K, Thoresen M, Lundin KEA, Henriksen C, Bøhn SK.

(7) Identification and characterization of plasma proteins associated with intra-amniotic inflammation and/or infection in women with preterm laborScientific reportsJune 25, 2024Cho HY, Lee JE, Park KH, Choi BY, Lee MJ, Jeong DE, Shin S.

(8) Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donorsScientific reportsJune 5, 2024de Rooij ENM, Hoogeveen EK, Romijn FPHTM, van der Kooy SW, Veighey KV, Dekker FW, van Kooten C, Cobbaert CM, de Fijter JW.

(9) Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infectionAnaerobeJune 1, 2024Ramakrishnan G, Young MK, Nayak U, Rigo I, Marrs AS, Gilchrist CA, Behm BW, Madden GR, Petri WA Jr.

(10) Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitusCardiovascular diabetologyApril 29, 2024Grannes H, Ueland T, Simeone P, Liani R, Guagnano MT, Aukrust P, Michelsen AE, Birkeland K, di Castelnuovo A, Cipollone F, et al.

(11) The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes MellitusJournal of clinical medicineApril 26, 2024Xu S, Hultström M, Larsson A, Lipcsey M, Lindskog C, Bülow S, Frithiof R, Venge P.

(12) Potential Utility of Urinary Follistatin as a Non-Invasive Indicator of Acute Tubular Damage in Patients with Acute Kidney InjuryCellsMarch 16, 2024Nagayama I, Takayanagi K, Nagata D, Hasegawa H, Maeshima A.

(13) Serum Lipocalin-2 Levels as a Biomarker in Pre- and Post-Pubertal Klinefelter Syndrome Patients: A Pilot StudyInternational journal of molecular sciencesFebruary 12, 2024Paparella R, Ferraguti G, Fiore M, Menghi M, Micangeli G, Tarani F, Ligotino A, Messina MP, Ceccanti M, Minni A, et al.

(14) Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic ImpactsInternational journal of molecular sciencesNovember 18, 2023Lablad Y, Vanhomwegen C, De Prez E, Antoine MH, Hasan S, Baudoux T, Nortier J.

(15) Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in DenmarkBMJ openSeptember 12, 2023Ravn EJ, Hasific S, Thomassen M, Hjortebjerg R, Bach Laursen K, Diederichsen A, Bistrup C, Øvrehus KA.

(16) No impact of a high-fat meal coupled with intermittent hypoxemia on acute kidney injury biomarkers in adults with and without obstructive sleep apneaPhysiological reportsSeptember 1, 2023Goulet N, Tetzlaff EJ, Morin R, Mauger JF, Amaratunga R, Kenny GP, Imbeault P.

(17) Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter TrialJournal of clinical medicineJuly 24, 2023Blesl A, Borenich A, Gröchenig HP, Novacek G, Primas C, Reinisch W, Kutschera M, Illiasch C, Hennlich B, Steiner P, et al.

(18) Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injuryClinical Kidney JournalFebruary 6, 2023Ander Vergara, Kaiming Wang, Daniele Colombo, Mahmoud Gheblawi, Jaslyn Rasmuson, Rupasri Mandal, Franca Del Nonno, Brian Chiu, James W Scholey, María José Soler, et al.using commercially available human enzyme-linked immunosorbent assay kits (DY933-05, DRT100, DRT200 and DY1757-05; R&D Systems, Minneapolis, MN, USA). Kidney samples and immunofluorescence studies Paraffin-embedded

(19) Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 TherapyCancersNovember 10, 2022Cao Z, Burvenich IJ, Zhao K, Senko C, Glab J, Fogliaro R, Liu Z, Jose I, Puthalakath H, Hoogenraad NJ, et al.

(20) Antenatal maternal depression, early life inflammation and neurodevelopment in a South African birth cohortBrain, behavior, and immunityOctober 1, 2022Naudé PJW, Pariante C, Hoffman N, Koopowitz SM, Donald KA, Zar HJ, Stein DJ.

Be the First to Write a Review!

Lipocalin-2/NGAL ELISA

Human Lipocalin-2/NGAL DuoSet ELISA

Lipocalin-2/NGAL ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (44)

Reviews

Lipocalin-2/NGAL ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map